AU3460897A - Medicinal compositions - Google Patents
Medicinal compositionsInfo
- Publication number
- AU3460897A AU3460897A AU34608/97A AU3460897A AU3460897A AU 3460897 A AU3460897 A AU 3460897A AU 34608/97 A AU34608/97 A AU 34608/97A AU 3460897 A AU3460897 A AU 3460897A AU 3460897 A AU3460897 A AU 3460897A
- Authority
- AU
- Australia
- Prior art keywords
- medicinal compositions
- medicinal
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18938096A JP2002241272A (en) | 1996-07-18 | 1996-07-18 | Medicinal composition |
JP8-189380 | 1996-07-18 | ||
PCT/JP1997/002448 WO1998003162A1 (en) | 1996-07-18 | 1997-07-15 | Medicinal compositions |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU18911/99A Division AU1891199A (en) | 1996-07-18 | 1999-01-19 | Medicinal compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3460897A true AU3460897A (en) | 1998-02-10 |
Family
ID=16240353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU34608/97A Abandoned AU3460897A (en) | 1996-07-18 | 1997-07-15 | Medicinal compositions |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2002241272A (en) |
AU (1) | AU3460897A (en) |
WO (1) | WO1998003162A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002324026B2 (en) * | 1996-07-18 | 2005-07-14 | Novartis Ag | Pharmaceutical compositions |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11209277A (en) * | 1998-01-19 | 1999-08-03 | Yoshitomi Pharmaceut Ind Ltd | Pharmaceutical composition |
GB9624038D0 (en) * | 1996-11-19 | 1997-01-08 | Sandoz Ltd | Organic compounds |
EP0990440B1 (en) * | 1997-02-27 | 2008-10-29 | Novartis AG | Pharmaceutical composition comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol, a lecithin and a saccharide |
JP4627356B2 (en) | 1999-06-30 | 2011-02-09 | 松森 昭 | Drugs for preventing or treating viral myocarditis |
US6423739B1 (en) | 2000-02-23 | 2002-07-23 | Daiichi Pharmaceutical Co., Ltd. | Method for aiding cerebral recovery following neurodegeneration |
CA2421893A1 (en) | 2000-08-31 | 2002-03-07 | Merck And Co., Inc. | Phosphate derivatives as immunoregulatory agents |
HUE028247T2 (en) * | 2003-04-08 | 2016-12-28 | Novartis Ag | Solid oral composition comprising a S1P receptor agonist and a sugar alcohol |
JP4838497B2 (en) * | 2004-04-09 | 2011-12-14 | キッセイ薬品工業株式会社 | Pharmaceutical composition for prevention or treatment of rejection after liver transplantation |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58148816A (en) * | 1982-02-27 | 1983-09-05 | Nippon Zenyaku Kogyo Kk | Low irritant thiamulin injection |
TW200402B (en) * | 1990-08-13 | 1993-02-21 | Senju Pharma Co | |
JPH0616547A (en) * | 1992-07-01 | 1994-01-25 | Wakamoto Pharmaceut Co Ltd | Antiphlogistic ophthalmic solution |
KR0155015B1 (en) * | 1992-10-21 | 1998-12-01 | 고우야 마사시 | 2-amino-1,3-propanediol compound and immunosuppressant |
JPH07228532A (en) * | 1993-04-22 | 1995-08-29 | Senju Pharmaceut Co Ltd | Water-soluble solution, method for improving solubility of its active ingredient and stabilization thereof |
JPH07316065A (en) * | 1994-05-25 | 1995-12-05 | Fujisawa Pharmaceut Co Ltd | Pharmaceutical preparation of fr 901469 substance |
PT778263E (en) * | 1994-08-22 | 2002-06-28 | Mitsubishi Pharma Corp | COMPOSITION OF BENZENE AND ITS PHARMACEUTICAL UTILIZATION |
JPH08175985A (en) * | 1994-12-26 | 1996-07-09 | Lion Corp | Ophthalmic solution |
ATE279185T1 (en) * | 1995-12-28 | 2004-10-15 | Mitsubishi Pharma Corp | 2-AMINO-2-(2-(4-OCTYLPHENYL)ETHYL)PROPANE-1,3-DI L CONTAINING MEDICINAL PRODUCT FOR TOPICAL USE FOR THE TREATMENT OF DISEASES CAUSED BY A DISRUPTION OF THE IMMUNE SYSTEM |
-
1996
- 1996-07-18 JP JP18938096A patent/JP2002241272A/en active Pending
-
1997
- 1997-07-15 AU AU34608/97A patent/AU3460897A/en not_active Abandoned
- 1997-07-15 WO PCT/JP1997/002448 patent/WO1998003162A1/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002324026B2 (en) * | 1996-07-18 | 2005-07-14 | Novartis Ag | Pharmaceutical compositions |
Also Published As
Publication number | Publication date |
---|---|
WO1998003162A1 (en) | 1998-01-29 |
JP2002241272A (en) | 2002-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4762797A (en) | Pharmaceutical compositions | |
AU5136998A (en) | Medicinal composition | |
AU2967597A (en) | Pharmaceutical compositions | |
AU6513298A (en) | Therapeutic compositions | |
AUPN411195A0 (en) | Medicinal composition | |
AU3777897A (en) | Pharmaceutical compositions | |
AU8107998A (en) | Pharmaceutical compositions | |
AU5317598A (en) | Novel pharmaceutical compositions | |
AU5157898A (en) | Hnf3delta compositions | |
GB9610359D0 (en) | Pharmaceutical compositions | |
AU2531295A (en) | Pharmaceutical composition | |
AU9343098A (en) | Pharmaceutical composition | |
AU3460897A (en) | Medicinal compositions | |
ZA979726B (en) | Pharmaceutical compositions | |
GB9613457D0 (en) | Pharmaceutical compositions | |
GB9606429D0 (en) | Pharmaceutical compositions | |
AU4326197A (en) | Pharmaceutical compositions | |
AU4457597A (en) | Pharmaceutical compositions | |
AUPN862596A0 (en) | Pharmaceutical compositions | |
AU1544195A (en) | Pharmaceutical compositions | |
AU1427895A (en) | Pharmaceutical compositions | |
GB9610136D0 (en) | Pharmaceutical compositions | |
AU2896897A (en) | Oral pharmaceutical compositions | |
AU3452997A (en) | Vaccine compositions | |
AUPN876196A0 (en) | Medicinal composition |